Literature DB >> 11812493

Interleukin-6 is required for parasite specific response and host resistance to Trypanosoma cruzi.

Wenda Gao1, Miercio A Pereira.   

Abstract

Infection with Trypanosoma cruzi, the agent of Chagas' disease, results in elevated levels of interleukin-6 (IL-6) in serum and infected tissues. However, it remains unknown whether IL-6 plays a role in host defence against T. cruzi. To determine whether IL-6 underlies disease progression, we followed the time course of T. cruzi-infected mice bearing IL-6 +/+ and minus sign/minus sign genotypes, respectively. We found that IL-6 minus sign/minus sign mice were more susceptible to T. cruzi infection as they exhibited about 3-fold higher parasitaemia and died earlier than wild-type animals. Unlike what might be expected, T. cruzi-infected IL-6 minus sign/minus sign mice did not show at peak infection a decrease in the secretion of IFN-gamma, a Th1 cytokine crucial for controlling the parasite. Instead, they exhibited a much reduced splenocyte recall response to T. cruzi antigens. Our results suggest that IL-6 mediates anti-parasite protective responses against T. cruzi.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11812493     DOI: 10.1016/s0020-7519(01)00322-8

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  25 in total

1.  Induction of immunoglobulin G1, interleukin-6 and interleukin-10 by Taenia crassiceps metacestode carbohydrates.

Authors:  Senarath Dissanayake; Nasir Khan; Allen Shahin; Shanaka Wijesinghe; Miodrag Lukic
Journal:  Immunology       Date:  2002-12       Impact factor: 7.397

2.  Dose-dependent induction of IL-6 by plant-derived proteases in vitro.

Authors:  B Rose; C Herder; H Löffler; G Meierhoff; N C Schloot; M Walz; S Martin
Journal:  Clin Exp Immunol       Date:  2006-01       Impact factor: 4.330

3.  Toll-like receptor-2 and interleukin-6 mediate cardiomyocyte protection from apoptosis during Trypanosoma cruzi murine infection.

Authors:  Nicolás Eric Ponce; Roxana Carolina Cano; Eugenio Antonio Carrera-Silva; Ana Paula Lima; Susana Gea; Maria Pilar Aoki
Journal:  Med Microbiol Immunol       Date:  2011-10-09       Impact factor: 3.402

4.  Role of interleukin-6 in mortality from and physiologic response to sepsis.

Authors:  Daniel G Remick; Gerald Bolgos; Shannon Copeland; Javed Siddiqui
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

5.  Concomitant Benznidazole and Suramin Chemotherapy in Mice Infected with a Virulent Strain of Trypanosoma cruzi.

Authors:  Eliziária C Santos; Rômulo D Novaes; Marli C Cupertino; Daniel S S Bastos; Raphael C Klein; Eduardo A M Silva; Juliana L R Fietto; André Talvani; Maria T Bahia; Leandro L Oliveira
Journal:  Antimicrob Agents Chemother       Date:  2015-07-13       Impact factor: 5.191

6.  Early antibiotic administration but not antibody therapy directed against IL-6 improves survival in septic mice predicted to die on basis of high IL-6 levels.

Authors:  Dinesh Vyas; Pardis Javadi; Peter J Dipasco; Timothy G Buchman; Richard S Hotchkiss; Craig M Coopersmith
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2005-06-09       Impact factor: 3.619

Review 7.  Parasite-host glycan interactions during Trypanosoma cruzi infection: trans-Sialidase rides the show.

Authors:  Oscar Campetella; Carlos A Buscaglia; Juan Mucci; María Susana Leguizamón
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2020-01-20       Impact factor: 5.187

8.  Transcriptome profile of Trypanosoma cruzi-infected cells: simultaneous up- and down-regulation of proliferation inhibitors and promoters.

Authors:  Takako Shigihara; Muneaki Hashimoto; Noriko Shindo; Takashi Aoki
Journal:  Parasitol Res       Date:  2007-12-05       Impact factor: 2.289

Review 9.  The biology and therapeutic potential of interleukin 27.

Authors:  Marcel Batten; Nico Ghilardi
Journal:  J Mol Med (Berl)       Date:  2007-02-10       Impact factor: 5.606

10.  Analysis of the dynamics of infiltrating CD4(+) T cell subsets in the heart during experimental Trypanosoma cruzi infection.

Authors:  Cristina Sanoja; Sofía Carbajosa; Manuel Fresno; Núria Gironès
Journal:  PLoS One       Date:  2013-06-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.